University of Texas at Austin Human Performance Laboratory
Austin, Texas, 78712, United States
NCT Number: NCT03089437
The effects of 12 hours of prolonged standing will be compared to prolonged standing on a high fat tolerance test the following day. Plasma triglycerides, insulin, and glucose will be measured in a crossover study design.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Austin, Texas, 78712, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-
Exclusion criteria
Subject will stand for 12 hours and undergo a high fat tolerance test the subsequent day
Subject will sit for 12 hours and undergo a high fat tolerance test the subsequent day
Time frame: 6 hours
The area under the curve for plasma triglycerides from hourly samples during a 6 hour high fat tolerance test
Time frame: 6 hours
The area under the curve for plasma insulin from hourly samples during a 6 hour high fat tolerance test
Time frame: 6 hours
The area under the curve for plasma glucose from hourly samples during a 6 hour high fat tolerance test
University of Texas at Austin
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01447745
Arterial Occlusive Diseases, Arteriosclerosis
Québec, Canada
View Trial DetailsNCT03697382
Arterial Occlusive Diseases, Arteriosclerosis
Austin, Texas, United States
View Trial DetailsNCT03352063
Arterial Occlusive Diseases, Arteriosclerosis
Austin, Texas, United States
View Trial DetailsNCT03098446
Arterial Occlusive Diseases, Arteriosclerosis
Austin, Texas, United States
View Trial Details